Contineum Therapeutics (CTNM) Short Interest Ratio & Short Volume $3.98 -0.03 (-0.63%) Closing price 07/3/2025 02:42 PM EasternExtended Trading$4.07 +0.10 (+2.42%) As of 07/3/2025 04:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Contineum Therapeutics Short Interest DataContineum Therapeutics (CTNM) has a short interest of 774,100 shares, representing 5.73% of the float (the number of shares available for trading by the public). This marks a 28.84% increase in short interest from the previous month. The short interest ratio (days to cover) is 7.4, indicating that it would take 7.4 days of the average trading volume of 90,588 shares to cover all short positions.Current Short Interest774,100 sharesPrevious Short Interest600,800 sharesChange Vs. Previous Month+28.84%Dollar Volume Sold Short$3.43 millionShort Interest Ratio7.4 Days to CoverLast Record DateJune 15, 2025Outstanding Shares25,870,000 sharesFloat Size13,500,000 sharesShort Percent of Float5.73%Today's Trading Volume143,855 sharesAverage Trading Volume90,588 sharesToday's Volume Vs. Average159% Short Selling Contineum Therapeutics? Sign up to receive the latest short interest report for Contineum Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCTNM Short Interest Over TimeCTNM Days to Cover Over TimeCTNM Percentage of Float Shorted Over Time Contineum Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/2025774,100 shares $3.43 million +28.8%5.7%7.4 $4.43 5/31/2025600,800 shares $2.17 million -1.0%4.5%6.7 $3.62 5/15/2025606,900 shares $2.39 million +5.1%4.5%8 $3.94 4/30/2025577,600 shares $2.37 million -16.2%4.3%8.8 $4.11 4/15/2025688,900 shares $2.83 million -0.1%5.1%10.9 $4.11 3/31/2025689,300 shares $4.81 million -13.1%5.1%10.8 $6.98 3/15/2025792,900 shares $5.29 million -3.1%5.9%10 $6.67 2/28/2025818,300 shares $5.76 million -3.6%6.1%9.5 $7.04 2/15/2025848,400 shares $6.56 million -2.4%6.3%9.6 $7.73 1/31/2025869,400 shares $8.51 million -7.0%6.2%9.4 $9.79 Get the Latest News and Ratings for CTNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Contineum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2025934,400 shares $12.11 million -8.4%6.6%9.8 $12.96 12/31/20241,020,000 shares $14.94 million +3.7%7.3%10.7 $14.65 12/15/2024983,600 shares $13.80 million -5.4%7.0%9.9 $14.03 11/30/20241,040,000 shares $15.51 million -1.0%7.4%12.9 $14.91 11/15/20241,050,000 shares $18.07 million -6.3%7.5%13.3 $17.21 10/31/20241,120,000 shares $18.77 million +17.6%7.9%15.6 $16.76 10/15/2024952,400 shares $15.66 million +2.8%6.7%14.9 $16.44 9/30/2024926,700 shares $17.74 million +13.9%6.5%13.8 $19.14 9/15/2024813,700 shares $15.60 million -2.9%5.8%10.8 $19.17 8/31/2024837,800 shares $16.33 million +3.1%5.9%10.2 $19.49 8/15/2024812,800 shares $15.11 million +2.0%5.7%9.9 $18.59 7/31/2024796,800 shares $15.98 million -0.5%8.1%9.3 $20.06 7/15/2024800,800 shares $16.82 million No Change8.2%9.2 $21.00 CTNM Short Interest - Frequently Asked Questions What is Contineum Therapeutics' current short interest? Short interest is the volume of Contineum Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 774,100 shares of CTNM short. 5.73% of Contineum Therapeutics' shares are currently sold short. Learn More on Contineum Therapeutics' current short interest. What is a good short interest ratio for Contineum Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CTNM shares currently have a short interest ratio of 7.0. Learn More on Contineum Therapeutics's short interest ratio. What is a good short interest percentage for Contineum Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.73% of Contineum Therapeutics' floating shares are currently sold short. Is Contineum Therapeutics' short interest increasing or decreasing? Contineum Therapeutics saw a increase in short interest in June. As of June 15th, there was short interest totaling 774,100 shares, an increase of 28.8% from the previous total of 600,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Contineum Therapeutics' float size? Contineum Therapeutics currently has issued a total of 25,870,000 shares. Some of Contineum Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Contineum Therapeutics currently has a public float of 13,500,000 shares. How does Contineum Therapeutics' short interest compare to its competitors? 5.73% of Contineum Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Contineum Therapeutics: Tyra Biosciences, Inc. (16.41%), Valneva SE Sponsored ADR (0.00%), aTyr Pharma, Inc. (15.85%), Mereo BioPharma Group plc - Sponsored ADR (5.30%), Cullinan Therapeutics, Inc. (16.59%), Amylyx Pharmaceuticals, Inc. (6.19%), Siga Technologies Inc. (7.56%), COMPASS Pathways PLC Sponsored ADR (5.89%), Precigen, Inc. (16.85%), Tourmaline Bio, Inc. (17.78%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Contineum Therapeutics stock? Short selling CTNM is an investing strategy that aims to generate trading profit from Contineum Therapeutics as its price is falling. CTNM shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Contineum Therapeutics? A short squeeze for Contineum Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CTNM, which in turn drives the price of the stock up even further. How often is Contineum Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CTNM, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies Tyra Biosciences Short Squeeze Valneva Short Squeeze aTyr Pharma Short Squeeze Mereo BioPharma Group Short Squeeze Cullinan Therapeutics Short Squeeze Amylyx Pharmaceuticals Short Squeeze Siga Technologies Short Squeeze COMPASS Pathways Short Squeeze Precigen Short Squeeze Tourmaline Bio Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CTNM) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Contineum Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Contineum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.